Hereditary tyrosinemia type I (chronic form): pathologic findings in the liver
- PMID: 2536631
- DOI: 10.1016/0046-8177(89)90179-2
Hereditary tyrosinemia type I (chronic form): pathologic findings in the liver
Abstract
Hereditary tyrosinemia type I presents with either acute hepatic failure in the neonatal period or later in infancy with progressive liver dysfunction secondary to cirrhosis. The inevitably fatal outcome in those children with the chronic form has been transformed with the advent of liver transplantation. Native livers from five children who received allografts were studied pathologically and compared with earlier hepatic biopsies in two of these patients that had been performed several years before transplantation. Our findings support the conclusion that a sequence of morphologic changes from the initial micronodular cirrhosis through an intermediate mixed cirrhotic pattern to macronodular cirrhosis occurs. The micronodular phase is transitory, over a period of only a few months, since mixed micronodular macronodular cirrhosis was already present in the livers of children who received transplants by 11 months of age. Focal hepatocellular dysplasia was present in one of the livers with mixed cirrhosis but was not identified in the other two cases. Macronodular cirrhosis accompanied two cases of hepatocellular carcinoma in this study. In order to preclude the latter complication, liver replacement is necessary before the age of 2 years.
Similar articles
-
Hepatic regenerating nodules in hereditary tyrosinemia.AJR Am J Roentgenol. 1987 Aug;149(2):391-3. doi: 10.2214/ajr.149.2.391. AJR Am J Roentgenol. 1987. PMID: 3300223
-
Liver cell dysplasia and early liver transplantation in hereditary tyrosinemia.Mod Pathol. 1990 Nov;3(6):694-701. Mod Pathol. 1990. PMID: 2175899
-
The occurrence of hepatoma in the chronic form of hereditary tyrosinemia.J Pediatr. 1976 Mar;88(3):434-8. doi: 10.1016/s0022-3476(76)80259-4. J Pediatr. 1976. PMID: 173827
-
Tyrosinaemia type I: orthotopic liver transplantation as the only definitive answer to a metabolic as well as an oncological problem.J Inherit Metab Dis. 1989;12 Suppl 2:339-42. doi: 10.1007/BF03335416. J Inherit Metab Dis. 1989. PMID: 2556611 Review. No abstract available.
-
Tyrosinemia: the Quebec experience.Clin Invest Med. 1996 Oct;19(5):311-6. Clin Invest Med. 1996. PMID: 8889268 Review.
Cited by
-
Visceral pathology of hereditary tyrosinemia type I.Am J Hum Genet. 1990 Aug;47(2):317-24. Am J Hum Genet. 1990. PMID: 2378357 Free PMC article.
-
Liver Transplantation for Pediatric Hepatocellular Carcinoma: A Systematic Review.Cancers (Basel). 2022 Mar 2;14(5):1294. doi: 10.3390/cancers14051294. Cancers (Basel). 2022. PMID: 35267604 Free PMC article. Review.
-
Deficient DNA-ligase activity in the metabolic disease tyrosinemia type I.Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12614-8. doi: 10.1073/pnas.95.21.12614. Proc Natl Acad Sci U S A. 1998. PMID: 9770534 Free PMC article.
-
Current strategies for the treatment of hereditary tyrosinemia type I.Paediatr Drugs. 2006;8(1):47-54. doi: 10.2165/00148581-200608010-00004. Paediatr Drugs. 2006. PMID: 16494511 Review.
-
Case of hepatocellular carcinoma in a patient with hereditary tyrosinemia in the post-newborn screening era.World J Hepatol. 2017 Mar 28;9(9):487-490. doi: 10.4254/wjh.v9.i9.487. World J Hepatol. 2017. PMID: 28396719 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical